Ifetroban
From Wikipedia, the free encyclopedia
 |
This article needs additional citations for verification. (April 2010) (Learn how and when to remove this template message) |
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
3-[2-({(1S,2R,3S)-3-[4-(Pentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]hept-2-yl}methyl)phenyl]propanoic acid
|
|
| Identifiers | |
| CAS Number | 143443-90-7 |
| PubChem | CID 23724921 |
| ChemSpider | 58452 |
| UNII | E833KT807K  |
| KEGG | D04500 |
| ChEMBL | CHEMBL2146062 |
| Chemical data | |
| Formula | C25H32N2O5 |
| Molar mass | 440.53 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
Ifetroban is a potent and selective thromboxane receptor antagonist.[1]
Synthesis[edit]
References[edit]
- ^ Dockens, RC; Santone, KS; Mitroka, JG; Morrison, RA; Jemal, M; Greene, DS; Barbhaiya, RH (August 2000). "Disposition of Radiolabeled Ifetroban in Rats, Dogs, Monkeys, and Humans" (PDF). Drug Metabolism and Disposition: the Biological Fate of Chemicals. 28 (8): 973–80. PMID 10901709. Retrieved 5 October 2016.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
